2022 Maserati Levante GT

3.0 L • V6 • 4×4 • AT

ZN661XUA6NX388884

Highlights
Condition
Run and drive
Seller
Unknown
Key included
Yes
Docs
Good
History
3 records
Drive
3.0 L • V6 • 4×4 • AT
Odometer
41,021 mi ≈ 66,017 km
Primary damage
Rear end
Secondary damage
Front end
Docs
CA • Dealer Clean
Extra
Auction
VIN
ZN661XUA6NX388884
Lot number
81075525
Copart
Sale status
Sold
Location
San Bernardino, CA
Description
Fuel type
Gasoline
Body color
Gray
Body type
SUV
Trim
GT
All sales final. Always run reports before bid

Sharing our own experience

Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.

How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides

Popular Maserati models

BiturboCoupeGhibli
GranTurismoGrecaleLevante
MC20Quattroporte

2022 Maserati Levante GT • 3.0 L • V6 • 4×4 • Automatic • Copart Lot: 81075525 • VIN: ZN661XUA6NX388884

Find out more about this 2022 Maserati Levante GT, available at the Copart salvage car auction as lot 81075525 in San Bernardino, CA. This car has Rear end main damage. It is listed with Run and drive start condition code. Odometer shows 41,021 mi. This Gray Maserati Levante SUV is equipped with Gasoline 3.0 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for ZN661XUA6NX388884 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.

We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.